Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Net Income towards Common Stockholders (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Net Income towards Common Stockholders for 15 consecutive years, with $27.5 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 357.35% to $27.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $77.2 million through Dec 2025, up 483.08% year-over-year, with the annual reading at $77.2 million for FY2025, 483.08% up from the prior year.
  • Net Income towards Common Stockholders hit $27.5 million in Q4 2025 for Ani Pharmaceuticals, up from $26.3 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $27.5 million in Q4 2025 to a low of -$24.6 million in Q3 2024.
  • Historically, Net Income towards Common Stockholders has averaged -$906600.0 across 5 years, with a median of -$1.3 million in 2021.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 25451.85% in 2022 and later skyrocketed 1623.23% in 2024.
  • Year by year, Net Income towards Common Stockholders stood at -$24.3 million in 2021, then surged by 80.88% to -$4.6 million in 2022, then surged by 116.11% to $749000.0 in 2023, then tumbled by 1526.17% to -$10.7 million in 2024, then skyrocketed by 357.35% to $27.5 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for ANIP at $27.5 million in Q4 2025, $26.3 million in Q3 2025, and $8.1 million in Q2 2025.